NCT06991556
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06991556
Title An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | NLD | ITA | FRA | ESP | DEU | CZE | AUS

Facility Status City State Zip Country Details
University of California San Diego - Moores Cancer Center RECRUITING La Jolla California 92093-0658 United States Details
Rocky Mountain Cancer Centers RECRUITING Denver Colorado 80218 United States Details
Emory University School of Medicine-Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
XCancer Omaha LLC RECRUITING Omaha Nebraska 68130 United States Details
Fox Chase Cancer Center RECRUITING Philadelphia Pennsylvania 19111 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Sarah Cannon Research Institute RECRUITING Nashville Tennessee 37203 United States Details
Urology San Antonio RECRUITING San Antonio Texas 78229 United States Details
Virginia Oncology Associates RECRUITING Norfolk Virginia 23502 United States Details
Fred Hutch Cancer Research RECRUITING Seattle Washington 98109 United States Details
Novartis Investigative Site RECRUITING Adelaide South Australia 5000 Australia Details
Novartis Investigative Site RECRUITING Clayton Victoria 3168 Australia Details
Novartis Investigative Site RECRUITING Brno 656 53 Czechia Details
Novartis Investigative Site RECRUITING Olomouc 779 00 Czechia Details
Novartis Investigative Site RECRUITING Prague 150 06 Czechia Details
Novartis Investigative Site RECRUITING Nice Alpes Maritimes 06189 France Details
Novartis Investigative Site RECRUITING Marseille 13273 France Details
Novartis Investigative Site RECRUITING Quint-Fonsegrives 31130 France Details
Novartis Investigative Site RECRUITING Suresnes 92150 France Details
Novartis Investigative Site RECRUITING Hamburg 20246 Germany Details
Novartis Investigative Site RECRUITING Lübeck 23538 Germany Details
Novartis Investigative Site RECRUITING Nürtingen 72622 Germany Details
Novartis Investigative Site RECRUITING Trento TN 38122 Italy Details
Novartis Investigative Site RECRUITING Verona VR 37134 Italy Details
Novartis Investigative Site RECRUITING Zwolle Overijssel 8025 AB Netherlands Details
Novartis Investigative Site RECRUITING Dordrecht South Holland 3318 AT Netherlands Details
Novartis Investigative Site RECRUITING Hoofddorp 2134 TM Netherlands Details
Novartis Investigative Site RECRUITING Schiedam 3118 JH Netherlands Details
Novartis Investigative Site RECRUITING Kielce 25-640 Poland Details
Novartis Investigative Site RECRUITING Olsztyn 10-288 Poland Details
Novartis Investigative Site RECRUITING Oświęcim 32-600 Poland Details
Novartis Investigative Site RECRUITING Skorzewo 60-185 Poland Details
Novartis Investigative Site RECRUITING Singapore 119074 Singapore Details
Novartis Investigative Site RECRUITING Singapore 169608 Singapore Details
Novartis Investigative Site RECRUITING Singapore S308433 Singapore Details
Novartis Investigative Site RECRUITING Seoul Korea 03080 South Korea Details
Novartis Investigative Site RECRUITING Seoul 06351 South Korea Details
Novartis Investigative Site RECRUITING Santander Cantabria 39008 Spain Details
Novartis Investigative Site RECRUITING Badajoz Extremadura 06080 Spain Details
Novartis Investigative Site RECRUITING Lugo Galicia 27003 Spain Details
Novartis Investigative Site RECRUITING Barcelona 08036 Spain Details
Novartis Investigative Site RECRUITING Tainan 70403 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field